Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W T Yates

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Advanced Drug Delivery Reviews|November 25, 2024
Integrated pharmacokinetic-pharmacodynamic and agent-based modelling in drug development: Current status and future perspectivesJames W T Yates
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 15, 2008
Mathematical properties and parameter estimation for transit compartment pharmacodynamic modelsJames W T Yates
Computer Methods and Programs in Biomedicine|May 5, 2009
An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREMEJames W T Yates
Journal of Pharmacokinetics and Pharmacodynamics|March 29, 2006
Structural identifiability of physiologically based pharmacokinetic modelsJames W T Yates
JCO Clinical Cancer Informatics|October 28, 2020
Clone Wars: Quantitatively Understanding Cancer Drug ResistanceJames W T Yates, Hitesh Mistry
Journal of Pharmaceutical Sciences|August 21, 2007
On the volume of distribution at steady state and its relationship with two-compartmental modelsJames W T Yates, Philip A Arundel
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2023
Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncologyJames W T Yates, Hitesh B Mistry
Cancer Research|October 3, 2019
Quantifying Preexisting Resistant and Persister Populations-LetterHitesh B Mistry, James W T Yates
Computer Methods and Programs in Biomedicine|January 17, 2012
Estimating insulin sensitivity from glucose levels only: Use of a non-linear mixed effects approach and maximum a posteriori (MAP) estimationJames W T Yates, Edmund M Watson
Clinical and Translational Science|October 30, 2021
How translational modeling in oncology needs to get the mechanism just rightJames W T Yates, David A Fairman
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Advanced Drug Delivery Reviews|November 25, 2024
Integrated pharmacokinetic-pharmacodynamic and agent-based modelling in drug development: Current status and future perspectivesJames W T Yates
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 15, 2008
Mathematical properties and parameter estimation for transit compartment pharmacodynamic modelsJames W T Yates
Computer Methods and Programs in Biomedicine|May 5, 2009
An implementation of the Expectation-Maximisation (EM) algorithm for population pharmacokinetic-pharmacodynamic modelling in ACSLXTREMEJames W T Yates
Journal of Pharmacokinetics and Pharmacodynamics|March 29, 2006
Structural identifiability of physiologically based pharmacokinetic modelsJames W T Yates
JCO Clinical Cancer Informatics|October 28, 2020
Clone Wars: Quantitatively Understanding Cancer Drug ResistanceJames W T Yates, Hitesh Mistry
Journal of Pharmaceutical Sciences|August 21, 2007
On the volume of distribution at steady state and its relationship with two-compartmental modelsJames W T Yates, Philip A Arundel
CPT: Pharmacometrics & Systems Pharmacology|September 29, 2023
Skipping a pillar does not make for strong foundations: Pharmacokinetic-pharmacodynamic reasoning behind the shape of dose-response relationships in oncologyJames W T Yates, Hitesh B Mistry
Cancer Research|October 3, 2019
Quantifying Preexisting Resistant and Persister Populations-LetterHitesh B Mistry, James W T Yates
Computer Methods and Programs in Biomedicine|January 17, 2012
Estimating insulin sensitivity from glucose levels only: Use of a non-linear mixed effects approach and maximum a posteriori (MAP) estimationJames W T Yates, Edmund M Watson
Clinical and Translational Science|October 30, 2021
How translational modeling in oncology needs to get the mechanism just rightJames W T Yates, David A Fairman
Pageof 7